Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Researchers have found in a new research that children with inflammatory skin conditions such as atopic dermatitis, psoriasis ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Kymera Therapeutics, Inc.’s KYMR share price has surged by 5.21%, which has investors questioning if this is right time to sell.

Investing.com -- Galderma (SIX: GALD) shares jumped more than 7% on Thursday after the company posted first-quarter results ...

Complete BiomX Inc. stock information by Barron's. View real-time PHGE stock price and news, along with industry-best analysis.

Allergies are among the most common health issues affecting people worldwide, often leading to symptoms such as sneezing, itching, rashes, and breathing difficulties. At the core of most allergic ...